Prospeo
Hero Section BackgroundHero Section Background
Navicyte Biotechnologies

Navicyte Biotechnologies Revenue

Biotechnology Research1-10 Employees

$

Navicyte Biotechnologies revenue & valuation

Annual revenue$342,220
Revenue per employee$86,000
Estimated valuation?$1,100,000
Total fundingNo funding

Key Contact at Navicyte Biotechnologies

Flag of US

Michael Donzanti

Chief Executive Officer

Company overview

HeadquartersXX
Website
NAICS541714
Employees1-10

About Navicyte Biotechnologies

At Navicyte, we are reinventing how immune-modulating drugs are delivered to increase efficacy, safety, and flexibility for drug developers. We offer: Efficacy. Expands therapeutic index by more than 500-fold in pre-clinical models. Flexibility. Compatible with small molecules, proteins, nucleic acids, vaccines, and adjuvants. Safety. Reduces off-target exposure and lowers required therapeutic doses by up to 85%. Innovation. Tunable release kinetics and immune-targeted delivery with FDA/GMP manufacturing compatibility.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Navicyte Biotechnologies has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Navicyte Biotechnologies has never raised funding before.

Frequently asked questions

Navicyte Biotechnologies is located in XX.
Navicyte Biotechnologies generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
Navicyte Biotechnologies has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Navicyte Biotechnologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles